IL20RB and colorectal carcinoma: Future studies leveraging multicenter prospective cohorts, spatial and single-cell omics and functional dissection of IL20RB signaling are warranted to confirm the clinical utility of the ITH score and to refine therapeutic strategies for high-ITH CRC subgroups.